TY - JOUR
T1 - Author Correction
T2 - Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics (Nature Communications, (2020), 11, 1, (467), 10.1038/s41467-020-14309-w)
AU - Ast, Julia
AU - Arvaniti, Anastasia
AU - Fine, Nicholas H.F.
AU - Nasteska, Daniela
AU - Ashford, Fiona B.
AU - Stamataki, Zania
AU - Koszegi, Zsombor
AU - Bacon, Andrea
AU - Jones, Ben J.
AU - Lucey, Maria A.
AU - Sasaki, Shugo
AU - Brierley, Daniel I.
AU - Hastoy, Benoit
AU - Tomas, Alejandra
AU - D’Agostino, Giuseppe
AU - Reimann, Frank
AU - Lynn, Francis C.
AU - Reissaus, Christopher A.
AU - Linnemann, Amelia K.
AU - D’Este, Elisa
AU - Calebiro, Davide
AU - Trapp, Stefan
AU - Johnsson, Kai
AU - Podewin, Tom
AU - Broichhagen, Johannes
AU - Hodson, David J.
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - The original version of this Article contained an error in the Methods section, when reporting ethical approval related to the generation of hESCs, which read: ‘hESC (WA01/H1; hPSCreg name WAe001-A) (obtained from WiCell) were generated by the originating institute with informed consent and ethical approval from the Robert-Koch Institut, Berlin (Az.3.04.02/0101) and NIH (NIHhESC-10- 0043). Studies with hESC (WA01/H1) were approved by the BC Children’s and Women’s Hospital Human Research Ethics Board (Approval #H09-00676)’. However, the cells were purchased from WiCell (Wisconsin) and the Robert-Koch Institute and NIH were not involved in the study. The sentence has now been corrected to state: ‘hESC (WA01/H1; hPSCreg name WAe001-A) were purchased from WiCell (Wisconsin) (full details including ethics and informed consent available at hPSCreg, cell line WAe001-A). Studies with hESC (WA01/H1) were approved by the BC Children’s and Women’s Hospital Human Research Ethics Board (Approval #H09-00676)’. This has been corrected in both the PDF and HTML versions of the Article.
AB - The original version of this Article contained an error in the Methods section, when reporting ethical approval related to the generation of hESCs, which read: ‘hESC (WA01/H1; hPSCreg name WAe001-A) (obtained from WiCell) were generated by the originating institute with informed consent and ethical approval from the Robert-Koch Institut, Berlin (Az.3.04.02/0101) and NIH (NIHhESC-10- 0043). Studies with hESC (WA01/H1) were approved by the BC Children’s and Women’s Hospital Human Research Ethics Board (Approval #H09-00676)’. However, the cells were purchased from WiCell (Wisconsin) and the Robert-Koch Institute and NIH were not involved in the study. The sentence has now been corrected to state: ‘hESC (WA01/H1; hPSCreg name WAe001-A) were purchased from WiCell (Wisconsin) (full details including ethics and informed consent available at hPSCreg, cell line WAe001-A). Studies with hESC (WA01/H1) were approved by the BC Children’s and Women’s Hospital Human Research Ethics Board (Approval #H09-00676)’. This has been corrected in both the PDF and HTML versions of the Article.
UR - http://www.scopus.com/inward/record.url?scp=85092229784&partnerID=8YFLogxK
U2 - 10.1038/s41467-020-19101-4
DO - 10.1038/s41467-020-19101-4
M3 - Comment/debate
C2 - 33037231
AN - SCOPUS:85092229784
SN - 2041-1723
VL - 11
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 5160
ER -